Page last updated: 2024-08-24

ibopamine and Disease Exacerbation

ibopamine has been researched along with Disease Exacerbation in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Craig, JE; Landers, J; Ullrich, K2
Brusini, P; Salvetat, ML; Tosoni, C; Zeppieri, M1
Petrie, CJ; van Veldhuisen, DJ; Voors, AA1
Boomsma, F; Brouwer, J; Dunselman, PH; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ1
Bazzato, G; Bignamini, AA; Bonomini, M; Bonomini, V; Brancaccio, D; Cappelli, P; Cossu, M; De Biase, V; Docci, D; Fanciulli, E; Feletti, C; Fracasso, A; Galmozzi, C; La Manna, G; Locatelli, F; Marai, P; Mioli, V; Mosconi, G; Oldrizzi, L; Piccoli, G; Roccatello, D; Scarpioni, L; Sorba, GB; Stefoni, S; Sverzellati, E1

Trials

5 trial(s) available for ibopamine and Disease Exacerbation

ArticleYear
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
    Clinical & experimental ophthalmology, 2015, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pupil; Tomography, Optical Coherence; Tonometry, Ocular; Visual Fields

2015
Ibopamine challenge testing becomes negative following successful trabeculectomy surgery.
    Clinical & experimental ophthalmology, 2016, Volume: 44, Issue:3

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Glaucoma; Humans; Intraocular Pressure; Male; Prospective Studies; Tonometry, Ocular; Trabeculectomy

2016
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
    International journal of cardiology, 2009, Jan-24, Volume: 131, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Young Adult

2009
Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
    The American journal of cardiology, 1995, Apr-15, Volume: 75, Issue:12

    Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Disease Progression; Dopamine Agonists; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Neurotransmitter Agents; Norepinephrine; Physical Exertion; Placebos; Renin; Stroke Volume; Ventricular Function, Left

1995
Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial.
    American journal of nephrology, 1996, Volume: 16, Issue:6

    Topics: Adolescent; Aged; Creatinine; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Humans; Kidney; Kidney Failure, Chronic; Linear Models; Logistic Models; Male; Middle Aged

1996

Other Studies

1 other study(ies) available for ibopamine and Disease Exacerbation

ArticleYear
Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
    Eye (London, England), 2016, Volume: 30, Issue:6

    Topics: Aged; Deoxyepinephrine; Disease Progression; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mydriatics; Ocular Hypertension; Ophthalmoscopy; Prospective Studies; Risk Factors; Tonometry, Ocular; Visual Field Tests; Visual Fields

2016